Location:        Kim Son – Bellaire
10603 Bellaire Blvd
Houston, TX 77072
Phone No:  281-598-1777

Date:   THURSDAY, APRIL 18, 2024
Time:   5:30 PM – 9:00 PM

Course Objectives:

Early oral squamous cell carcinoma (OSCC) diagnosis is critical for improving the prognosis and treatment outcome. Oral Potentially Malignant Disorders (OPMDs) are a group of mucosal disorders that may precede the diagnosis of OSCC. The majority of these OPMDs may not progress to OSCC but rather represent oral lesions/disorders in which cancer development is more likely than in their clinically normal mucosa. The clinical management of OPMD consists of biopsying for risk stratification and lifelong surveillance. This presentation aims to discuss the role of minimally invasive optical imaging and brush biopsy as tools for risk assessment, biopsy site selection of OPMDs during initial evaluation, and subsequent surveillance.”

Presenter:   

Dr. Nadarajah Vigneswaran is a professor in the Department of Diagnostics and Biomedical Sciences at the UTHealth School of Dentistry in Houston (UTSD-H). He holds joint appointments in the Department of Stem Cell Transplantation and Cellular Therapy at the M.D. Anderson Cancer Center as a Clinical Professor, and in the Department of Pathology at the UTHealth McGovern Medical School as an Adjunct Professor. He directs the Oral and Maxillofacial Pathology residency program at the UTHealth School of Dentistry in Houston. He is an Oral and Maxillofacial Pathologist involved in diagnosing and managing patients with various oral mucosal disorders. He directs the UTSD-Houston Oral and Maxillofacial Pathology Biopsy service, which processes approximately 5,000 cases per year and is one of the largest dental services for the country’s dental profession. He received his Bachelor of Dental Surgery (BDS) degree from the University of Peradeniya, Sri Lanka. He earned his Dr.Med.Dent degree in Immunopathology at the University of Erlangen, Germany. He obtained his Doctor of Dental Medicine (DMD) degree from the University of Alabama at Birmingham (UAB) School of Dentistry. He completed his Oral and Maxillofacial Pathology residency at the Emory University School of Medicine and his Dental Oncology Fellowship at the UAB School of Dentistry. He is actively involved in clinical and laboratory-based research on oral cancer and its precursors. He has more than 175 peer-reviewed scientific publications in high-impact journals and 12 chapters in medical and dental textbooks. He is an invited contributor to the WHO Classification of Tumours, 5th edition, (1) Genetic tumor syndromes and (2) Head and Neck tumors, published by The International Agency for Research on Cancer (IARC).

Meeting Schedule:
Registration:   5:30 PM – 6:00 PM
Dinner:            6:00 PM – 7:00 PM
Lecture:           7:00 PM – 9:00 PM

Menu:             7 Course Dinner
*Vegetarian Options Available

Parking:          Complimentary

2  CE HRS     AGD CODES 310

Registration Deadline:  April 11, 2024

Registration Fee:         Members/Guests $60            Residents/D4 Students $20               Non-Members $120      

On-site Fee:                 Members/Guests $80             Residents/D4 Students $40               Non-Members $140